scholarly journals Adult Mortality After Preterm Birth—Time to Translate Findings Into Clinical Practice

2021 ◽  
Vol 4 (1) ◽  
pp. e2033361
Author(s):  
Casey Crump
2021 ◽  
Vol 12 (2) ◽  
pp. 94-98
Author(s):  
Marcelo Santucci Franca ◽  
Alan Roberto Hatanaka ◽  
Antonio Fernandes Moron

Cervical pessary is a new treatment for preterm birth and have obtained a lot of space in clinical practice because its real efficacy, which unconsidered the bias produced by some research. There is a lack of evidence about cervical pessary in many aspects and only those who handle this device every day can note and call for attention. Experience is the central point about cervical pessary in this article, and important centers with training and expertise must be taken the front of this issue, because low experience probably is one of the causes of contradictory results in literature. In fact, we have a lot of aspects that need attention and never were treated because always the efficacy is questioned and do not open space for other important aspects. We have a lot of o issues to discuss during this article such as the indication of a cervical pessary, the needs of guidelines about pessary, including a learning curve of pessary treatment, the relevant aspects about insertion of the device, its association with other medications, needs for hospitalization, which is the best management for the vaginal discharge pessary related, how to handle the pelvic pain after insertion, the urinary symptoms, the obstipation, and the inhibition of preterm labor during pessary treatment, and finally, what are the relevant aspects about the withdrawal of cervical pessary?


2013 ◽  
Vol 23 (1) ◽  
pp. 1-6 ◽  
Author(s):  
Nathalie Auger ◽  
Michal Abrahamowicz ◽  
Alison L. Park ◽  
Willy Wynant

2014 ◽  
Vol 2014 ◽  
pp. 1-6 ◽  
Author(s):  
Stefan C. Kane ◽  
Fabricio da Silva Costa ◽  
Shaun Brennecke

Adverse obstetric outcomes, such as preeclampsia, preterm birth, gestational diabetes, and fetal growth restriction, are poorly predicted by maternal history and risk factors alone, especially in nulliparae. The ability to predict these outcomes from the first trimester would allow for the early initiation of prophylactic therapies, institution of an appropriate model and location of care, and recruitment of a truly “high risk” population to clinical trials of interventions to prevent or ameliorate these conditions. To this end, development of adequately sensitive and specific predictive tests for these outcomes has become a significant focus of perinatal research. This paper reviews the biomarkers involved in these multiparametric tests and also outlines the performance of these tests and issues regarding their introduction into clinical practice.


2014 ◽  
Vol 34 (4) ◽  
pp. 209-210 ◽  
Author(s):  
J. Zeitlin ◽  
K. Szamotulska ◽  
N. Drewniak ◽  
A.D. Mohangoo ◽  
J. Chalmers ◽  
...  
Keyword(s):  

2000 ◽  
Vol 182 (5) ◽  
pp. 1103-1106 ◽  
Author(s):  
Rachael L. Lopez ◽  
Jennifer A. Francis ◽  
Thomas J. Garite ◽  
Johanna M. Dubyak

Placenta ◽  
2020 ◽  
Vol 98 ◽  
pp. 6-12
Author(s):  
Natasha Singh ◽  
Elizabeth Bonney ◽  
Tom McElrath ◽  
Ronald F. Lamont ◽  
Andrew Shennan ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document